Pfizer (PFE) News Today → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Free PFE Stock Alerts $27.17 +1.55 (+6.05%) (As of 05/1/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineQ1 2024 Pfizer Inc Earnings Call Transcriptgurufocus.com - May 2 at 1:01 AMRaymond James Financial Services Advisors Inc. Grows Stake in Pfizer Inc. (NYSE:PFE)marketbeat.com - May 1 at 11:16 PMPfizer stock gains 7% after earnings beat, company calls dividend 'secure'msn.com - May 1 at 8:39 PMPfizer (PFE) Q1 2024 Earnings Call Transcriptfool.com - May 1 at 8:39 PMWhy Pfizer Stock Blasted More Than 6% Higher Todayfool.com - May 1 at 5:55 PMPFE Earnings: Pfizer Rises After Smashing Q1 Estimatesmsn.com - May 1 at 3:39 PMPfizer (NYSE:PFE) Stock Price Up 3.8%marketbeat.com - May 1 at 1:59 PMPfizer Stock Gets Boost From Better-Than-Expected Earningsinvestopedia.com - May 1 at 1:46 PMPfizer raises guidance amid cost savingsmsn.com - May 1 at 10:38 AMPfizer Stock Rises as Outlook Rises After Earnings Beatfinance.yahoo.com - May 1 at 10:38 AMPfizer Inc (PFE) Q1 2024 Earnings: Adjusted EPS Surpasses Expectations Amidst Revenue Declinefinance.yahoo.com - May 1 at 10:38 AMStocks to Watch Wednesday: Starbucks, Pfizer, CVS, Amazonfinance.yahoo.com - May 1 at 10:38 AMPfizer raises full-year outlook, stock rises on Q1 beatfinance.yahoo.com - May 1 at 10:38 AMPfizer (NYSE:PFE) Releases FY24 Earnings Guidancemarketbeat.com - May 1 at 9:35 AMPfizer revenues fall 19% due to lower COVID-related product demandproactiveinvestors.com - May 1 at 8:14 AMPfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid salescnbc.com - May 1 at 7:13 AMAmazon, Pfizer And 3 Stocks To Watch Heading Into Wednesdaybenzinga.com - May 1 at 7:01 AMPfizer beats profit estimates on cost cuts, RSV vaccine salesreuters.com - May 1 at 6:50 AMPfizer (NYSE:PFE) Trading 0.4% Higher marketbeat.com - April 30 at 3:37 PMPfizer and Genmab Receive FDA Approval for Cervical Cancer Drugbaystreet.ca - April 30 at 2:54 PMPfizer Q1 Earnings Preview: Covid assets to remain the focus this quartermsn.com - April 30 at 2:54 PM7 Safe Haven Stocks That Can Withstand the Market's Worst Meltdownsinvestorplace.com - April 30 at 1:50 PMPfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earningsbenzinga.com - April 30 at 12:01 PMFDA approves Labcorp companion diagnostic for Pfizer gene therapyfinance.yahoo.com - April 30 at 9:54 AM5 Top Stocks to Buy in Mayfool.com - April 30 at 7:45 AMWhy I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fistfool.com - April 30 at 5:50 AMForget Nvidia: Prominent Billionaires Are Selling It and Buying These 2 Ultra-High-Yield Dividend Stocks Insteadfool.com - April 30 at 5:06 AMIs 7%-Yielding Pfizer Stock A Buy On The Dip Before Q1?seekingalpha.com - April 30 at 4:53 AMPfizer,Genmab: FDA Grants Full Approval For TIVDAK To Treat Recurrent Or Metastatic Cervical Cancermarkets.businessinsider.com - April 29 at 11:47 PMVan ECK Associates Corp Raises Position in Pfizer Inc. (NYSE:PFE)marketbeat.com - April 29 at 8:49 PMThese 3 High-Yield Stocks Have Been Growing Their Dividends Non-Stop, And Analysts Expect Their Share Prices To Climbfinance.yahoo.com - April 29 at 6:46 PMUPDATE 1-US FDA grants full approval for Pfizer's cervical cancer drugfinance.yahoo.com - April 29 at 6:46 PMFDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancerfinance.yahoo.com - April 29 at 6:46 PMTIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancerfinance.yahoo.com - April 29 at 6:46 PMFDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancerbusinesswire.com - April 29 at 6:40 PMTIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancerbusinesswire.com - April 29 at 6:40 PMTIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancerglobenewswire.com - April 29 at 6:40 PMUS FDA grants full approval for Pfizer's cervical cancer drugreuters.com - April 29 at 4:09 PMPfizer (NYSE:PFE) Trading Up 1.3%marketbeat.com - April 29 at 3:17 PMThese Pharmaceutical Firms Are On Sale: Abbvie, Pfizer, And Gileadmsn.com - April 29 at 1:46 PMPfizer gene therapy made in NC gets FDA approval. It costs $3.5M per dosebizjournals.com - April 29 at 1:46 PM3 Ultra-Yield Dividend Stocks Retirees Can Trust247wallst.com - April 29 at 10:20 AMLabcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia Bprnewswire.com - April 29 at 7:09 AMPfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meetingbusinesswire.com - April 29 at 6:45 AM3 Dividend Stocks to Buy on the Dip: April 2024investorplace.com - April 29 at 6:00 AMRaymond James & Associates Raises Position in Pfizer Inc. (NYSE:PFE)marketbeat.com - April 28 at 10:53 PMThe Motley Fool: Pfizer offers a pfat 6.4% dividenddallasnews.com - April 28 at 2:54 PM5 Of The Highest Yielding Blue Chip Stocks To Buy Now247wallst.com - April 28 at 7:45 AM3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Streetfool.com - April 28 at 5:50 AMPfizer (NYSE:PFE) Stock Price Up 0.3%americanbankingnews.com - April 28 at 3:18 AM Get Pfizer News Delivered to You Automatically Sign up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s last act as President (Ad)You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. For the full story, click here. PFE Media Mentions By Week PFE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PFE News Sentiment▼0.520.35▲Average Medical News Sentiment PFE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PFE Articles This Week▼8334▲PFE Articles Average Week Get Pfizer News Delivered to You Automatically Sign up to receive the latest news and ratings for PFE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Bristol-Myers Squibb News Zoetis News AbbVie News Merck & Co., Inc. News Johnson & Johnson News Sanofi News Abbott Laboratories News Vertex Pharmaceuticals News Novartis News Regeneron Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:PFE) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace😱 This phenomenon is smashing regular market gainsMillPubA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyAI “wealth window” is closing June 25thParadigm Press4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pfizer Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
